MedTrace Logo

Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1) : Multi-centre, Prospective, Randomized Controlled Study

NCT00935194 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2009-12-01

No results posted yet for this study

Summary

The purpose of this study is to determine whether Chinese medicinal herbs are effective and safe for treating novel influenza A (H1N1) infection.

Conditions

Interventions

DRUG

oseltamivir

75mg,bid,for 5 days

OTHER

blank

no antiviral therapy

DRUG

chinese medicinal herbs

200ml,p.o,qid,for 5 days

DRUG

oseltamivir and chinese medicinal herbs

oseltamivir:75mg,p.o,bid,for 5 days; chinese medicinal herbs:200ml,p.o,qid,for 5 days

Sponsors & Collaborators

  • Capital Medical University

    lead OTHER

Principal Investigators

  • Chen Wang, Doctor · Capital Medical University affiliated Beijing Chaoyang Hospital, Beijing Respiratory Medicine Insititute

  • Qingquan Liu, Docter · Beijing Chinese Traditional Medicine University affiliated Dongzhimen Hospital

  • Yu Mao, Doctor · Beijing Ditan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2009-11-30
Completion
2009-11-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00935194 on ClinicalTrials.gov